CMND vs CMPX

Clearmind Medicine Inc. vs Compass Therapeutics, Inc. — Valuation Comparison 2026

CMND

Biotechnology
Clearmind Medicine Inc.
Quality
1.6
out of 10
Value Trap
Price
$2.45
Last close
Models
6/13
Active
VS

CMPX

Biotechnology
Compass Therapeutics, Inc.
Quality
5.3
out of 10
Value Trap
30
LOW
Price
$2.41
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType CMND Fair ValueCMND Upside CMPX Fair ValueCMPX Upside
Bayesian DCF Intrinsic $0.65 -73.5% $0.79 -67.1%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.50 -4.7% $0.18 -90.4%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for CMND vs CMPX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CMND vs CMPX — Which Stock Is More Undervalued?

CMPX scores higher with a 5.3/10 quality rating vs CMND's 1.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Clearmind Medicine Inc. (CMND) and Compass Therapeutics, Inc. (CMPX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CMND currently trades at $2.45 with a QOC of 1.6/10, while CMPX trades at $2.41 with a QOC of 5.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).